Alto Neuroscience, Inc. (ANRO)

Alto Neuroscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021
Revenue	0	0	0.21
Gross Profit	0	0	0.21
Selling, General & Admin	7.52	5.5	3.9
Research & Development	30.29	23.69	8.37
Operating Expenses	37.81	29.19	12.27
Operating Income	-37.81	-29.19	-12.06
Interest Expense / Income	1.37	0	0
Other Expense / Income	-2.87	-1.48	-2.87
Pretax Income	-36.31	-27.71	-9.19
Net Income	-36.31	-27.71	-9.19
Shares Outstanding (Basic)	4	3	5
Shares Outstanding (Diluted)	4	3	5
Shares Change	8.27%	-35.80%	-
EPS (Basic)	-9.73	-8.04	-1.71
EPS (Diluted)	-9.73	-8.04	-1.71
Free Cash Flow	-33.92	-21.13	-9.94
Free Cash Flow Per Share	-9.09	-6.13	-1.85
Gross Margin	-	-	100.00%
Operating Margin	-	-	-5740.95%
Profit Margin	-	-	-4374.76%
Free Cash Flow Margin	-	-	-4734.29%
EBITDA	-34.28	-27.11	-9.04
EBITDA Margin	-	-	-4305.71%
Depreciation & Amortization	0.65	0.61	0.15
EBIT	-34.94	-27.71	-9.19
EBIT Margin	-	-	-4374.76%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).